SUMMARY The effect of indomethacin on rCBF was studied in cats anesthetized with Nembutal either under resting conditions or with temporary middle cerebral artery (MCA) occlusion. RCBF was measured by the microsphere method. In control animals (n = 3), indomethacin (4 mg/kg, i.v.) significantly reduced rCBF by about 25% in both cortex (from 44 ± 6 to 32 ± 3 ml/100 g/min, p < 0.001) and white matter (from 36 ± 4 to 26 ± 2 ml/100 g/min, p < 0.001). After MCA occlusion rCBF was markedly decreased in the sylvian region ipsilateral to occlusion (ischemic core) (from 38 ± 4 to 14 ± 2 ml/100 g/min in cortex, 4 animals). Although pretreatment with indomethacin (4 mg/kg) (4 animals) 30 min prior to occhision did not alter rCBF during ischemia, a marked enhancement of reactive hyperemia was observed in the ischemic core immediately upon reperfusion following 2 h occlusion (54 ± 1 1 untreated vs 95 ± 13 treated, p < 0.05). In the delayed postischemic period, namely 2 h after ^circulation, rCBF still remained to be higher in the animals treated with indomethacin (40 ± 6 untreated vs 96 ± 9 treated, p < 0.001). Such an effect of indomethacin for ameliorating postischemic blood flow in both the immediate and delayed period was less prominent in the adjacent area (penumbra) ipsilateral to occlusion. In the contralateral hemisphere, indomethacin caused slight reduction in rCBF during ischemia. An altered relationship between the actions of PGI 2 and TXA 2 has been proposed to occur at the blood-endothelium interface during reperfusion after ischemia in which a disproportionate synthesis of TXA 2 might be suppressed by indomethacin, whereas indomethacin dominantly suppresses PGI 2 synthesis under normal conditions.
AN ALTERED RELATIONSHIP between the actions of several prostaglandins (PGs) such as prostacyclin (PGIj) and thromboxane A 2 (TXA 2 ) may occur in pathological situations, whereas a balanced interaction is maintained under normal conditions. In addition to the general agreement that PGI 2 is produced in vascular endothelia, and TXA 2 in platelets, 1 there is increasing evidence that TXA 2 synthesis can also occur in the vascular endothelium, 2 " 9 where a dominant but opposing role of PGI 2 with respect to TXA 2 has been documented. Thus previous results which have shown a decrease in basal cerebral blood flow with indomethacin treatment 10 
"
18 might be indicative of preferential suppression of PGI 2 synthesis at the vascular endothelia, although indomethacin is thought to inhibit more or less all the products of cyclooxygenase. 19 In cerebral ischemia, a significant accumulation of cyclooxygenase products is known to occur, particularly when the ischemia is either transient 20 
22 or incomplete. 22 " 24 Although the pathogenetic role of accumulation of PGs in cerebral ischemia remains unclear, the improvement shown in cerebral microcirculation with indomethacin treatment following global cerebral ischemia suggests a reversal of roles: a relative dominance in TXA 2 level during this pathological situation. 2326 Accordingly the present study was aimed at exploring whether the above relationship can be al-
Material and methods
Adult mongrel cats weighing 3 to 4 kg were anesthetized with Nembutal® (30 mg/kg), paralyzed with Flaxedil®, and artificially ventilated with nitrous oxide/oxygen gas mixture via a cuffed endotracheal tube. Following catheterization to one femoral vein and two femoral arteries, one of the arterial catheters being introduced to the left cardiac ventricle, the animal was fastened on the stereotaxic frame in a sphinx like position. Systemic blood pressure and cardiac ventricular pressure were continuously monitored. Arterial blood gases were intermittently determined and maintained within normal limits throughout the experiment. Rectal temperature was continuously measured and kept between 36° and 38° C by an electrically heated blanket. Regional cerebral blood flow (rCBF) was measured by the microsphere method, using microspheres 15 /Am in diameter and labelled with scandium-46, strontium-85, cerium-141 and iodine-125. Preparation of the microspheres and calculation of rCBF values have been described in detail elsewhere. 27 In three animals rCBF was determined in a resting state before and 30 min after intravenous injection of 4 mg/kg of indomethacin (Sigma 0 ). The solution of indomethacin was prepared just prior to the experiment by dissolving 20 mg of indomethacin in 10 ml of a 0.5% sodium bicarbonate solution followed by addition of 10 ml of a phosphate buffer (Na 149.2, K 4.2, Cl 139.6, Phosphate 8.2 mM/L), thus yielding a 1 mg/ ml solution. The pH value was 7.45 ± 0.01 and the appropriate volume was delivered by an infusion pump (Braun 0 ) over 10 min. After the experiment, brain tissues weighing 100 to 200 mg were rapidly dissected from 9 regions of the cortex and subjacent white matter STROKE VOL 16, No 2, MARCH-APRIL 1985 in the cerebral hemisphere and the wet weight was determined after storing tissues in preweighed tightlysealed test tubes. A paired comparison by Student's ttest was made using the rCBF values against tissue wet weight before and after treatment.
In eight animals, MCA was occluded and subsequently reperfused with (n = 4) or without (n = 4) indomethacin pretreatment. Occlusion of MCA was performed by a Yasargil type aneurysm clip through a transorbital approach, and recirculation lasting 2 hours was achieved by removing the clip 2 hours after occlusion. Indomethacin (4 mg/kg) was given 30 min prior to the first determination of rCBF which was performed after the exposure of MCA but without occlusion. Immediately after the first rCBF measurement, the MCA was occluded. RCBF was determined subsequently 5 min after occlusion, and at 5 min and 2 hours upon recirculation. Occlusion and recirculation of MCA was clearly visible and successful under operative microscope in all animals. Brain tissues from both cortex and white matter were collected from 4 regions in the territory of MCA (ischemic core) and 4 regions adjacent to the core (penumbra) as in figure 1. Brain tissues in the hemisphere contralateral to occlusion were also sampled in the same way for interhemispheric comparison. The perfusion territory of MCA was previously determined and found to be consistent on the angioarchitectural basis by transventricular intravital perfusion of carbon black after modification of the single dye passage technique 28 ( fig. 2 ). Data were pooled from each group of animals and analysed either by unpaired Student's t-test between the treated and untreated groups or by analysis of variance test 29 to compare sequential changes in rCBF within the group.
Results

Effect of Indomethacin on Resting Blood Flow
There were no significant changes in blood pressure or blood gases before and after the administration of indomethacin (table 1) . A significant reduction in rCBF by around 25% was observed after the administration of indomethacin in both cortex and white matter of the normal brain (table 2) .
Changes of rCBF during and after Ischemia
Values of blood gases and blood pressure at each time of measurement of CBF in both treated and untreated groups did not yield significant level of statistical difference as shown in table 3. Changes in cortical CBF before, 5 min after occlusion (ischemia), 5 min (hyperemia) and 2 h upon recirculation (delayed) are summarized in figure 3 . RCBF before occlusion was lower throughout the brain in the treated group than in the untreated group, again showing the effect of indomethacin in decreasing CBF under resting conditions. However, in the core region ipsilateral to occlusion, the pre-occlusion values were lower than in other regions in both groups which might have been caused by some operative insult in exposing the MCA. Or, since the flow value was calculated against tissue wet weight and the tissues in the ischemic core developed massive water increase in this study, the CBF values in the core could be lower than those in the other regions without increase in water content. In the untreated group, a marked flow reduction in the core was followed by immediate hyperemia exceeding the contralateral flow upon recirculation and returned toward the pre-occlusion value 2 h later. In the penumbra the reduction in rCBF during ishemia and subsequent hyperemia were less marked. In the contralateral hemisphere, sequential values of rCBF during occlusion and upon recirculation stayed unchanged in the corresponding regions to core and penumbra, although there was tendency of slight reduction in rCBF in the area corresponding to core.
By contrast in the animals treated with indomethacin, striking and sustained increases in CBF were observed in the ipsilateral ischemic core in both the immediate and delayed period upon recirculation. The decrease in rCBF during ischemia in the core did not differ significantly irrespective of the indomethacin treatment. In the penumbral region ipsilateral to occlusion, such an effect for enhancing hyperemia was less marked. Contralaterally, indomethacin only displayed an effect of slight reduction in rCBF throughout the ischemia and recirculation period without developing any hyperemic stage.
CBF changes in the white matter were similar to those in the cortex (fig. 4) , where a significant and sustained increase of flow in the ischemic core following indomethacin treatment was also observed in the postischemic period. Occlusion and recirculation of MCA did not influence contralateral flow, where indomethacin had no effect, either. 
Discussion
Since the effect of indomethacin on resting CBF was first reported by Pickard et al, 10 there have been a number of reports which have shown CBF reduction by indomethacin in both normal and hypercapnic situations."' 8 In accordance with those reports, the present study in cats under barbiturate anesthesia showed a decrease in resting CBF. However, others have shown a total lack of effect on CBF. 30 " 32 As to the microsphere method, Busija & Heistad 32 did not observe any effect of indomethacin, while other workers" 18 observed CBF reduction. Explanation for these conflicting results is difficult but might have been caused by differences in the methods employed for CBF measurement, animal species or anesthetics.
Gaudet & Levine 20 first reported a marked accumulation of PGs upon reperfusion following global cerebral ischemia in the gerbil. The PGs which accumulated in the postischemic period were PGD 2 , P G F 2 Q , PGE 2 and to a lesser degree TXB 2 and 6-keto-PGF lo . Pretreatment with indomethacin almost completely inhibited this accumulation. 21 Thereafter similar results on the massive accumulation of PGs in cerebral ischemia were also obtained.
l5 ' 22> 23 Using reversible global ischemia in the rat, Shohami et al 22 reported an accumulation of PGE 2 , 6-keto-F la and TXB 2 during ischemia and upon reperfusion. Of interest to note was a further accumulation of TXB 2 upon reperfusion, whereas other PGs tended to be decreased. Pretreatment with indomethacin (4 mg/kg) prior to the induction of ischemia ameliorated the increases of these PGs, particularly of TXB 2 after recirculation.
The biosynthesis of prostaglandins is primarily determined by substrate availability as long as the minimum level of tissue oxygen is maintained. 33 Kagstrdm et al 34 assumed that high concentrations of arachidonic acid which accumulated during the ischemic period 35 
'
36 might trigger a burst of PG synthesis as soon as the tissue is reoxygenated. For the activity of cyclooxygenase, however, the presence of endoperoxides is paradoxically required. 33 ' 37 It may also be assumed that hydroperoxides formed in the lipoxygenase pathway (HPETEs) which is probably involved in cerebral ischemia 38 " 40 take part in the elucidation of clyclooxygenase activity. Once these hydroperoxides are formed and further converted to hydroxyacids by peroxydases, the active oxygen liberated concomitantly in this process is known to suppress the synthesis of PGI 2 but not TXA 2 , 4142 leading to imbalance between these opposing vasoactive substances in pathological situations.
The effect of indomethacin in ameliorating impaired postischemic reperfusion was first documented by Furlow and Hallenbeck. 25 Pretreatment with indomethacin 4 mg/kg one hour prior to ischemia improved the delayed hypoperfusion. 26 In the present study we could demonstrate that indomethacin increased postischemic flow either in the immediate period upon reperfusion or in the delayed period. The reactive hyperemia was much more enhanced and the flow still remained to be higher in the delayed period than in the untreated controls. Although the degree of interaction between PGI 2 and TXA 2 might be different in the immediate and delayed period after recirculation, a major contribution would seem to be the relative dominance of TXA 2 synthesis throughout the re-oxygenation period. The finding that such changes were most prominent in the core of ischemia indicates that re-oxygenation process propagates from this region but not from the periphery of ischemia. This enhanced postischemic blood flow by indomethacin was not a result from a difference in the level of ischemic flow, because indomethacin did not change this even in the presence of premorbid reduction of CBF. No such patterns as ischemia and hyperemia were noted in the contralateral hemisphere except for the effect of indomethacin in reducing blood flow as observed in normal conditions. Recently, Kagstrom et al 34 also demonstrated that indomethacin enhanced immediate reflow upon recirculation. They concluded that TXA 2 restricted the hyperemia. As to such an inversed effect of indomethacin on rCBF in health and disease, Okabe et al 17 has shown decrease in CBF in normal subjects, but increase in patients with recent stroke. It has been generally agreed that TXA 2 and PGI 2 interact at the blood-endothelium interface, with the site of synthesis being in the platelets for the former and vascular endothelia in the latter. 1 Recently, however, evidence of the production of TXA 2 in vascular endothelia has arisen which suggests that the ratio of PGI 2 synthesis to that of TXA 2 is greater under normal conditions. 2 " 9 Therefore the effect of indomethacin for decreasing resting CBF can be understood as a result from a greater suppression of PGI 2 synthesis. By contrast, following cerebral ischemia disproportionate synthesis of TXA 2 might occur, at least as judged by the amelioration of postischemic flow in the present study. As stated previously, arachidonic acid accumulated during the ischemic period is involved in the subsequent cascades after incorporation of oxygen either for cyclooxygenase reaction or for lipoxygenase reaction. Since the prostacyclin synthetase is selectively inhibited by peroxidase-derived products, possibly oxygen radicals in both pathways, 4142 disproportionate synthesis of TXA 2 is readily suspected. However, evidence for this hypothesis is still indirect on account of the rather non-specific inhibition of all prostaglandin synthesis by indomethacin, or the possibility that indomethacin may not be a pure cyclooxygenase inhibitor. 43 The recent discoveries of more specific thromboxane antagonist, either of synthetase 44 or of receptor 45 may be of value in order to clarify the mechanisms involved. In this regard, the resolution of experimental vasospasms by a TXA 2 synthetase inhibitor 46 also suggests a disproportionate synthesis of TXA 2 in pathological situations.
CORTEX
In summary, although there is strong evidence of disproportionate synthesis of TXA 2 in cerebral ischemia, the significance of PGs in the postischemic pathophysiology such as edema formation and ischemic brain damage remains unclear. Furthermore, whether the augmented reactive hyperemia caused by indomethacin is of actual benifit to neuronal recovery is open to question.
